TIDMODX

RNS Number : 2991H

Omega Diagnostics Group PLC

27 July 2023

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Notice of Final Results

Investor Presentation

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition products, confirms it will issue its final results for the year ended 31 March 2023 on Thursday 3 August 2023.

Analyst briefing

A briefing for analysts will take place in London on Thursday 3 August 2023 at 9:30 BST. To register and for more details please contact Walbrook PR on omega@walbrookpr.com .

Investor presentation

Jag Grewal, CEO and Chris Lea, CFO will provide a live presentation relating to the Final Results via the Investor Meet Company platform on Thursday 3 August 2023 at 16:30 BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics Group plc via:

https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor

Investors who already follow Omega Diagnostics Group plc on the Investor Meet Company platform will automatically be invited.

Contacts:

 
  Omega Diagnostics Group PLC                                        www.omegadx.com 
  Jag Grewal, Chief Executive Officer                                via Walbrook PR 
  Chris Lea, Chief Financial Officer 
 
  finnCap Ltd                                                     Tel: 020 7220 0500 
  Geoff Nash/Edward Whiley/George Dollemore 
   (Corporate Finance) 
  Alice Lane/Charlotte Sutcliffe (ECM) 
 
  Walbrook PR Limited                     Tel: 020 7933 8780 or omega@walbrookpr.com 
  Lianne Applegarth                                               Mob: 07584 391 303 
  Sam Allen                                                       Mob: 07502 558 258

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

www.omegadx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORFZGZNZVGGFZM

(END) Dow Jones Newswires

July 27, 2023 02:00 ET (06:00 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Omega Diagnostics Charts.